All the information you need about CLINIQUE DEVELOPPEMENT to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-07-13 | Public | 2021-12-31 | Complete |
| 2021-07-21 | Public | 2020-12-31 | Complete |
| 2020-06-16 | Public | 2019-12-31 | Consolidated |
| 2019-05-07 | Public | 2018-12-31 | Complete |
| 2018-05-09 | Public | 2017-12-31 | Complete |
| 2018-05-07 | Public | 2017-12-31 | Consolidated |
| 2017-05-03 | Public | 2016-12-31 | Simplified |
| 2017-04-18 | Public | 2016-12-31 | Complete |
| Name | CLINIQUE DEVELOPPEMENT |
| Siren | 442125274 |
| Closing | 2017-12-31 |
| Registry code | 7501 |
| Registration number | 34374 |
| Management number | 2003B17408 |
| Activity code | 6420Z |
| Closing date n-1 | 2016-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2018-05-07 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | K : Consolidated |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 75008 PARIS |
| 1 - Assets (balance sheet) | Gross amount N | Amortization year N | Net year N | Net year N-1 |
A1 ASSETS - Investments | 32 427 007.00 | 3 396 737.00 | 29 030 270.00 | 32 427 007.00 |
BJ TOTAL (I) | 144 996 548.00 | 31 788 531.00 | 113 208 017.00 | 144 996 548.00 |
BX Customers and related accounts | 6 599 942.00 | 310 405.00 | 6 289 537.00 | 6 599 942.00 |
BZ Other receivables | 19 177 296.00 | 5 912.00 | 19 171 384.00 | 19 177 296.00 |
CD Marketable securities | ||||
CF Cash and cash equivalents | 8 311 986.00 | 8 311 986.00 | 8 311 986.00 | |
CJ TOTAL (II) | 34 947 997.00 | 316 317.00 | 34 631 680.00 | 34 947 997.00 |
CO Grand total (0 to V) | 179 944 545.00 | 32 104 848.00 | 147 839 697.00 | 179 944 545.00 |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 133 186.00 | 88 783.00 | 133 186.00 | |
DB Share, merger, contribution premiums, etc. | 24 208 181.00 | 2 785 482.00 | 24 208 181.00 | |
DL TOTAL (I) | 36 047 939.00 | 13 410 925.00 | 36 047 939.00 | |
DR TOTAL (IV) | 4 539 459.00 | 2 174 582.00 | 4 539 459.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 81 080 306.00 | 22 509 390.00 | 81 080 306.00 | |
DX Trade payables and related accounts | 4 017 691.00 | 2 916 864.00 | 4 017 691.00 | |
EC TOTAL (IV) | 107 252 299.00 | 32 578 763.00 | 107 252 299.00 | |
EE Grand total (I to V) | 147 839 697.00 | 48 164 271.00 | 147 839 697.00 | |
P2 LIABILITIES - Gross Technical Reserves | 2 736 777.00 | 5 494 640.00 | 2 736 777.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FJ Net sales | 54 724 162.00 | |||
FQ Other income | 3 435 109.00 | |||
FR Total operating income (I) | 58 159 271.00 | |||
FX Taxes, duties, and similar payments | 3 895 106.00 | |||
FZ Social Security Contributions | 28 586 059.00 | |||
GA Operating Expenses - Depreciation and Amortization | 5 243 570.00 | |||
GE Other Expenses | 7 217.00 | |||
GF Total Operating Expenses (II) | 53 397 374.00 | |||
GG - OPERATING RESULT (I - II) | 4 761 897.00 | |||
GV - FINANCIAL INCOME (V - VI) | -1 875 757.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | 2 886 140.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HI - EXCEPTIONAL RESULT (VII - VIII) | 488 635.00 | 4 400 714.00 | 488 635.00 | |
HK Income tax | -24 524.00 | -829 655.00 | -24 524.00 | |
R3 Income Statement - Technical Result | 588 823.00 | 724 229.00 | 588 823.00 | |
R5 Net income of consolidated companies | 3 350 251.00 | 6 304 112.00 | 3 350 251.00 | |
R6 Group Income (Consolidated Net Income) | 2 761 428.00 | 5 579 883.00 | 2 761 428.00 | |
R7 Share of minority interests (Non-group income) | 24 649.00 | 85 244.00 | 24 649.00 | |
R8 Net income, group share (parent company share) | 2 736 779.00 | 5 494 640.00 | 2 736 779.00 | |
